Bruker Corporation  

(Public, NASDAQ:BRKR)   Watch this stock  
Find more results for BRKR
0.00 (0.00%)
Apr 16 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range     -
52 week 15.41 - 24.40
Open     -
Vol / Avg. 0.00/740,250.00
Mkt cap 3.49B
P/E 43.85
Div/yield     -
EPS 0.48
Shares 167.61M
Beta 1.07
Inst. own 67%
Apr 28, 2014
Q1 2014 Bruker Corporation Earnings Release (Estimated) Add to calendar
Feb 18, 2014
Q4 2013 Bruker Corporation Earnings Conference Call - Webcast
Feb 18, 2014
Q4 2013 Bruker Corporation Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '13) 2013
Net profit margin 6.50% 4.45%
Operating margin 11.05% 8.06%
EBITD margin - 11.39%
Return on average assets 7.34% 4.26%
Return on average equity 17.40% 10.32%
Employees 6,400 -
CDP Score - -


United States - Map
+1-978-6633660 (Phone)
+1-978-6635585 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Bruker Corporation (Bruker) is a global manufacturer of scientific instruments that address the rapidly evolving needs of a diverse array of customers in life science, pharmaceutical, biotechnology, clinical and molecular diagnostics research, as well as in materials and chemical analysis in various industries and government applications. The Company�s technology platforms include magnetic resonance technologies, mass spectrometry technologies, gas chromatography technologies, X-ray technologies, spark-optical emission spectroscopy, atomic force microscopy, stylus and optical metrology technology and infrared and Raman molecular spectroscopy technologies. Its manufacture and distribute a broad range of field analytical systems for chemical, biological, radiological, nuclear and explosives, or CBRNE, detection. In April 2012, it acquired SkyScan N.V. In September 2013, the Company announced that it has acquired Prairie Technologies, Inc.

Officers and directors

Frank H. Laukien Ph.D. Chairman of the Board, President, Chief Executive Officer
Age: 53
Bio & Compensation  - Reuters
Charles F. Wagner Jr. Chief Financial Officer, Executive Vice President
Age: 45
Bio & Compensation  - Reuters
Thomas W. Bachmann President of Bruker BioSpin Group
Bio & Compensation  - Reuters
Bernd Gewiese Ph.D. Co-President of Bruker BioSpin Corporation
Age: 55
Bio & Compensation  - Reuters
Werner E. Maas Ph.D. Co-President of Bruker BioSpin Corporation
Age: 49
Bio & Compensation  - Reuters
Mark R. Munch Ph.D. President of Bruker Nano, Inc. and Bruker MAT Group
Age: 51
Bio & Compensation  - Reuters
Juergen Srega President of Bruker CALID Group
Age: 58
Bio & Compensation  - Reuters
Anthony L. Mattacchione Senior Vice President - Corporate Finance and Accounting
Age: 49
Bio & Compensation  - Reuters
Michael Gunnar Knell Vice President - Finance, Chief Accounting Officer
Age: 36
Bio & Compensation  - Reuters
Richard M. Stein Secretary, Director
Age: 61
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance